Neurocrine Biosciences (NBIX) Tops Q4 EPS by 33c
Tweet
Share
E-mail
Get Alerts NBIX Hot Sheet
Price: $161.62 --0%
EPS Growth %: -5.5%
Financial Fact:
Total other income: 1.55M
Today's EPS Names:
JFIN, KEQU, LASE, More
EPS Growth %: -5.5%
Financial Fact:
Total other income: 1.55M
Today's EPS Names:
JFIN, KEQU, LASE, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q4 EPS of $1.54, $0.33 better than the analyst estimate of $1.21. Revenue for the quarter came in at $515.2 million versus the consensus estimate of $518.2 million.
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Ennis (EBF) Reports In-Line Q1 EPS
- Primoris cuts 2026 outlook on renewables cost overruns, COO exits
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
